AKT1 and head and neck squamous cell carcinoma: AKT1 isoform is predominantly upregulated in HNSCC and besides being associated with radioresistance mechanisms in HNSCC patients [38], more specifically at the AKT(Ser473) residue, it has been used as biomarker to identify HNSCC patients with high risk for treatment failure following radiotherapy [39].